Lymphoma, AIDS-Related  >>  Rituxan (rituximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rituxan (rituximab) / Roche
CATCH, NCT00799136: A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Completed
2
6
Canada
R-EPOCH and cART, Rituxan, Vepesid, Adriamycin, Vincristine, Cytoxan, Prednisone, Truvada, Sustiva
Ontario Clinical Oncology Group (OCOG), Hoffmann-La Roche
Lymphoma, AIDS Related, HIV Infections
12/12
09/13
NCT00310128: Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Withdrawn
2
0
US
cisplatin, cytarabine, etoposide, methylprednisolone, rituximab, yttrium Y 90 ibritumomab tiuxetan, antibody therapy, biological therapy, chemotherapy, monoclonal antibody therapy, radiation therapy, radioimmunotherapy, radioisotope therapy
AIDS Malignancy Consortium, National Cancer Institute (NCI)
AIDS-related Lymphoma, Adult Non-Hodgkin's Lymphoma, Anaplastic Large Cell Lymphoma
 
 
NCT01045889 / 2006-006047-30: High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk

Completed
2
27
Europe
Rituximab and CHOP regimen + PBSCT, Mabthera, cyclophosphamide, adryamicin, vincristine, prednisone, BiCNU, etoposide, aracytin, melphalan
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
HIV-related Lymphoma, HIV Infections
05/16
05/16

Download Options